☰

Sarah L. Kerns, Ph.D. - Publications

Affiliations: 
2007 Northwestern University, Evanston, IL 
Area:
Molecular Biology, Cell Biology
Tree Info Grants Similar researchers PubMed Report error

62/108 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2023 Oh JH, Lee S, Thor M, Rosenstein BS, Tannenbaum A, Kerns S, Deasy JO. Predicting the germline dependence of hematuria risk in prostate cancer radiotherapy patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 185: 109723. PMID 37244355 DOI: 10.1016/j.radonc.2023.109723  0.329
2020 Massi MC, Gasperoni F, Ieva F, Paganoni AM, Zunino P, Manzoni A, Franco NR, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Symonds PR, Johnson K, ... ... Kerns SL, et al. A Deep Learning Approach Validates Genetic Risk Factors for Late Toxicity After Prostate Cancer Radiotherapy in a REQUITE Multi-National Cohort. Frontiers in Oncology. 10: 541281. PMID 33178576 DOI: 10.3389/fonc.2020.541281  0.315
2020 Collado K, Kerns SL, Diefenbach MA, Peterson-Roth E, Koski R, Ostrer H, Stock RG, Mattessich M, Kaplan P, Rosenstein BS. Survey of Radiation Oncologists to Assess Interest and Potential Use of a Genetic Test Predicting Susceptibility for the Development of Toxicities After Prostate Cancer Radiation Therapy. Advances in Radiation Oncology. 5: 897-904. PMID 33083651 DOI: 10.1016/J.Adro.2020.03.019  0.387
2020 Marples B, Kerns S. Oncology Scan: Radiation Biology and Genomic Predictors of Response. International Journal of Radiation Oncology, Biology, Physics. 107: 393-397. PMID 32531379 DOI: 10.1016/J.Ijrobp.2020.04.008  0.321
2019 Bergom C, West CM, Higginson DS, Abazeed ME, Arun B, Bentzen SM, Bernstein JL, Evans JD, Gerber NK, Kerns SL, Keen J, Litton JK, Reiner AS, Riaz N, Rosenstein BS, et al. The implications of genetic testing on radiotherapy decisions: a guide for radiation oncologists. International Journal of Radiation Oncology, Biology, Physics. PMID 31381960 DOI: 10.1016/J.Ijrobp.2019.07.026  0.342
2019 Kerns SL, Fachal L, Dorling L, Barnett GC, Baran A, Peterson DR, Hollenberg M, Hao K, Narzo AD, Ahsen ME, Pandey G, Bentzen SM, Janelsins M, Elliott RM, Pharoah PDP, et al. Radiogenomics Consortium Genome-Wide Association Study Meta-analysis of Late Toxicity after Prostate Cancer Radiotherapy. Journal of the National Cancer Institute. PMID 31095341 DOI: 10.1093/Jnci/Djz075  0.432
2019 Yao S, Hu Q, Kerns S, Yan L, Onitilo AA, Misleh J, Young K, Lei L, Bautista J, Mohamed M, Mohile SG, Ambrosone CB, Liu S, Janelsins MC. Impact of chemotherapy for breast cancer on leukocyte DNA methylation landscape and cognitive function: a prospective study. Clinical Epigenetics. 11: 45. PMID 30867049 DOI: 10.1186/S13148-019-0641-1  0.315
2019 Schumacher FR, Olama AAA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, ... ... Kerns SL, et al. Author Correction: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. PMID 30622367 DOI: 10.1038/S41588-018-0330-6  0.321
2019 West C, Kerns S, Dorling L, Barnett G, Dearnaley D, Fachal L, Veldeman L, Parliament M, Vega A, Dunning A, Rosenstein B. OC-0374 GWAS identifies new susceptibility loci for late toxicity following prostate cancer radiotherapy Radiotherapy and Oncology. 133: S186. DOI: 10.1016/S0167-8140(19)30794-7  0.388
2019 Hall W, Baran A, Peterson D, Bergom C, Lawton C, Zhang H, Bylund K, Messing E, Chen Y, Morrow G, Kerns S. Characterization of the Host Immuno-Inflammatory State in Response to Radiation Therapy and Correlation with Patient Reported Toxicities In Prostate Adenocarcinoma, A Prospective Observational Trial International Journal of Radiation Oncology*Biology*Physics. 105: S114-S115. DOI: 10.1016/J.Ijrobp.2019.06.613  0.337
2019 Kang J, Strawderman R, Dearnaley D, Hall E, Burnet N, West C, Kerns S. Predicting Prostate Radiotherapy Toxicity in a Phase III Trial Using Clinical/Dosimetric Variables in Logistic Regression and Random Forest Models International Journal of Radiation Oncology*Biology*Physics. 105: E285. DOI: 10.1016/J.Ijrobp.2019.06.1820  0.302
2018 Kang J, Rancati T, Lee S, Oh JH, Kerns SL, Scott JG, Schwartz R, Kim S, Rosenstein BS. Machine Learning and Radiogenomics: Lessons Learned and Future Directions. Frontiers in Oncology. 8: 228. PMID 29977864 DOI: 10.3389/Fonc.2018.00228  0.349
2018 Dadaev T, Saunders EJ, Newcombe PJ, Anokian E, Leongamornlert DA, Brook MN, Cieza-Borrella C, Mijuskovic M, Wakerell S, Olama AAA, Schumacher FR, Berndt SI, Benlloch S, Ahmed M, Goh C, ... ... Kerns S, et al. Fine-mapping of prostate cancer susceptibility loci in a large meta-analysis identifies candidate causal variants. Nature Communications. 9: 2256. PMID 29892050 DOI: 10.1038/S41467-018-04109-8  0.394
2018 Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, Goh C, Brook MN, Sheng X, Fachal L, Dennis J, ... ... Kerns SL, et al. Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nature Genetics. PMID 29892016 DOI: 10.1038/S41588-018-0142-8  0.364
2018 Kerns S, Chuang KH, Hall W, Werner Z, Chen Y, Ostrer H, West C, Rosenstein B. Radiation biology and oncology in the genomic era. The British Journal of Radiology. 20170949. PMID 29888979 DOI: 10.1259/Bjr.20170949  0.399
2018 Kerns SL, Fung C, Monahan PO, Ardeshir-Rouhani-Fard S, Abu Zaid MI, Williams AM, Stump TE, Sesso HD, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger C, et al. Cumulative Burden of Morbidity Among Testicular Cancer Survivors After Standard Cisplatin-Based Chemotherapy: A Multi-Institutional Study. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2017770735. PMID 29617189 DOI: 10.1200/Jco.2017.77.0735  0.304
2018 Lee S, Kerns S, Ostrer H, Rosenstein B, Deasy JO, Oh JH. Machine Learning on a Genome-wide Association Study to Predict Late Genitourinary Toxicity After Prostate Radiation Therapy. International Journal of Radiation Oncology, Biology, Physics. PMID 29502932 DOI: 10.1016/J.Ijrobp.2018.01.054  0.447
2018 Termer NK, Richardson M, Adams MJ, Alongi A, Bellohusen P, Bruckner LB, Cowen R, Fritsch S, Hettler D, Kerns SL, Pandya C, Williams A, Constine LS. Meeting requirements for survivorship visits: Interventions for patient identification. Journal of Clinical Oncology. 36: 59-59. DOI: 10.1200/Jco.2018.36.7_Suppl.59  0.305
2018 Lee S, Oh J, Kerns S, Rosenstein B, Ostrer H, Deasy J. PV-0564: Predicting Genitourinary Toxicity by Machine Learning on Genome-Wide Single Nucleotide Polymorphisms Radiotherapy and Oncology. 127: S297-S298. DOI: 10.1016/S0167-8140(18)30874-0  0.302
2018 Kerns S, Fachal L, Dorling L, Barnett G, Burnet N, Sydes M, Dearnaley D, Dunning A, Pharoah P, Parliament M, Usmani N, de Ruyck K, Ostrer H, Rosenstein B, CaamaNo AG, et al. Meta-Analysis of Genome-Wide Association Studies (GWAS) of Late Toxicity in 3,874 Men Treated with Radiation for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 102: e738-e739. DOI: 10.1016/J.Ijrobp.2018.07.1976  0.428
2017 El Naqa I, Kerns SL, Coates J, Luo Y, Speers C, West CML, Rosenstein BS, Ten Haken RK. Radiogenomics and radiotherapy response modeling. Physics in Medicine and Biology. PMID 28657906 DOI: 10.1088/1361-6560/Aa7C55  0.304
2017 Azria D, Lapierre A, Gourgou S, De Ruysscher D, Colinge J, Lambin P, Brengues M, Ward T, Bentzen SM, Thierens H, Rancati T, Talbot CJ, Vega A, Kerns SL, Andreassen CN, et al. Data-Based Radiation Oncology: Design of Clinical Trials in the Toxicity Biomarkers Era. Frontiers in Oncology. 7: 83. PMID 28497027 DOI: 10.3389/Fonc.2017.00083  0.33
2017 Fung C, Sesso HD, Williams AM, Kerns SL, Monahan P, Abu Zaid M, Feldman DR, Hamilton RJ, Vaughn DJ, Beard CJ, Kollmannsberger CK, Cook R, Althouse S, Ardeshir-Rouhani-Fard S, Lipshultz SE, et al. Multi-Institutional Assessment of Adverse Health Outcomes Among North American Testicular Cancer Survivors After Modern Cisplatin-Based Chemotherapy. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. JCO2016703108. PMID 28240972 DOI: 10.1200/Jco.2016.70.3108  0.302
2017 Oh JH, Kerns S, Ostrer H, Powell SN, Rosenstein B, Deasy JO. Computational methods using genome-wide association studies to predict radiotherapy complications and to identify correlative molecular processes. Scientific Reports. 7: 43381. PMID 28233873 DOI: 10.1038/Srep43381  0.393
2017 Cole CL, Kleckner I, Kerns S, Asare M, Lin P, Kamen C, Janelsins M, Mustian K. Feasibility of Exercise for Improving Inflammation in Advance Stage Prostate Cancer Patients Medicine & Science in Sports & Exercise. 49: 270. DOI: 10.1249/01.Mss.0000517595.63003.0A  0.324
2017 Kerns SL, Fung C, Williams A, Zaid MIA, Sesso HD, Monahan P, Ardeshirrouhanifard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Huddart RA, Kim J, Kollmannsberger CK, Sahasrabudhe DM, et al. Clinical, sociodemographic, and behavioral factors associated with cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study. Journal of Clinical Oncology. 35: 10075-10075. DOI: 10.1200/Jco.2017.35.15_Suppl.10075  0.325
2017 Kerns S, Hao K, Stahl E, Rosenstein B, CaamaNo AG, Carballo A, Peleteiro P, Fachal L, Vega A, Dunning A, Sydes M, Hall E, Dearnaley D, West C, Ostrer H. Contribution of Common SNPs to Variability in Late Radiation Therapy Toxicity in Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 99: E601. DOI: 10.1016/J.Ijrobp.2017.06.2047  0.406
2016 Oh J, Kerns S, Ostrer H, Rosenstein B, Deasy J. SU-D-204-06: Integration of Machine Learning and Bioinformatics Methods to Analyze Genome-Wide Association Study Data for Rectal Bleeding and Erectile Dysfunction Following Radiotherapy in Prostate Cancer. Medical Physics. 43: 3333. PMID 28046236 DOI: 10.1118/1.4955611  0.409
2016 Kerns SL, Dorling L, Fachal L, Bentzen S, Pharoah PD, Barnes DR, Gómez-Caamaño A, Carballo AM, Dearnaley DP, Peleteiro P, Gulliford SL, Hall E, Michailidou K, Carracedo Á, Sia M, et al. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer. Ebiomedicine. PMID 27515689 DOI: 10.1016/J.Ebiom.2016.07.022  0.449
2016 Andreassen CN, Rosenstein BS, Kerns SL, Ostrer H, De Ruysscher D, Cesaretti JA, Barnett GC, Dunning AM, Dorling L, West CM, Burnet NG, Elliott R, Coles C, Hall E, Fachal L, et al. Individual patient data meta-analysis shows a significant association between the ATM rs1801516 SNP and toxicity after radiotherapy in 5456 breast and prostate cancer patients. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 27443449 DOI: 10.1016/J.Radonc.2016.06.017  0.374
2016 Ahmed M, Dorling L, Kerns S, Fachal L, Elliott R, Partliament M, Rosenstein BS, Vega A, Gómez-Caamaño A, Barnett G, Dearnaley DP, Hall E, Sydes M, Burnet N, Pharoah PD, et al. Common genetic variation associated with increased susceptibility to prostate cancer does not increase risk of radiotherapy toxicity. British Journal of Cancer. PMID 27070714 DOI: 10.1038/Bjc.2016.94  0.418
2016 Baijer J, Déchamps N, Perdry H, Morales P, Kerns S, Vasilescu A, Baulande S, Azria D, Roméo PH, Schmitz A. TNFSF10/TRAIL regulates human T4 effector memory lymphocyte radiosensitivity and predicts radiation-induced acute and subacute dermatitis. Oncotarget. PMID 26982083 DOI: 10.18632/Oncotarget.7893  0.335
2016 Herskind C, Talbot CJ, Kerns SL, Veldwijk MR, Rosenstein BS, West CM. Radiogenomics: A systems biology approach to understanding genetic risk factors for radiotherapy toxicity? Cancer Letters. PMID 26944314 DOI: 10.1016/J.Canlet.2016.02.035  0.342
2016 Kerns SL, Fung C, Williams A, Zaid MIA, Sesso HD, Monahan P, Ardeshir-Rouhani-Fard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Sahasrabudhe DM, Fossa SD, Einhorn LH, Travis LB. Cumulative burden of morbidity (CBM) among testicular cancer survivors (TCS) in the Platinum study. Journal of Clinical Oncology. 34: 10089-10089. DOI: 10.1200/Jco.2016.34.15_Suppl.10089  0.316
2016 Oh J, Kerns S, Ostrer H, Rosenstein B, Deasy J. EP-2058: A novel multi-SNP model predictive of erectile dysfunction following radiotherapy in prostate cancer Radiotherapy and Oncology. 119: S971. DOI: 10.1016/S0167-8140(16)33309-6  0.38
2015 Bourgier C, Kerns S, Gourgou S, Lemanski C, Gutowski M, Fenoglietto P, Romieu G, Crompton N, Lacombe J, Pèlegrin A, Ozsahin M, Rosenstein B, Azria D. Concurrent or sequential letrozole with adjuvant breast radiotherapy: Final results of the CO-HO-RT phase II randomized trial. Annals of Oncology : Official Journal of the European Society For Medical Oncology / Esmo. PMID 26681684 DOI: 10.1093/Annonc/Mdv602  0.34
2015 Kerns SL, Kundu S, Oh JH, Singhal SK, Janelsins M, Travis LB, Deasy JO, Janssens AC, Ostrer H, Parliament M, Usmani N, Rosenstein BS. The Prediction of Radiotherapy Toxicity Using Single Nucleotide Polymorphism-Based Models: A Step Toward Prevention. Seminars in Radiation Oncology. 25: 281-91. PMID 26384276 DOI: 10.1016/J.Semradonc.2015.05.006  0.385
2015 Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CM, Burnet NG. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity. Clinical Oncology (Royal College of Radiologists (Great Britain)). 27: 579-87. PMID 26166774 DOI: 10.1016/J.Clon.2015.06.013  0.354
2015 Seibold P, Behrens S, Schmezer P, Helmbold I, Barnett G, Coles C, Yarnold J, Talbot CJ, Imai T, Azria D, Koch CA, Dunning AM, Burnet N, Bliss JM, Symonds RP, ... ... Kerns SL, et al. XRCC1 Polymorphism Associated With Late Toxicity After Radiation Therapy in Breast Cancer Patients. International Journal of Radiation Oncology, Biology, Physics. 92: 1084-92. PMID 26072091 DOI: 10.1016/J.Ijrobp.2015.04.011  0.37
2014 Kerns SL, West CM, Andreassen CN, Barnett GC, Bentzen SM, Burnet NG, Dekker A, De Ruysscher D, Dunning A, Parliament M, Talbot C, Vega A, Rosenstein BS. Radiogenomics: the search for genetic predictors of radiotherapy response. Future Oncology (London, England). 10: 2391-406. PMID 25525847 DOI: 10.2217/Fon.14.173  0.358
2014 Fachal L, Gómez-Caamaño A, Barnett GC, Peleteiro P, Carballo AM, Calvo-Crespo P, Kerns SL, Sánchez-García M, Lobato-Busto R, Dorling L, Elliott RM, Dearnaley DP, Sydes MR, Hall E, Burnet NG, et al. A three-stage genome-wide association study identifies a susceptibility locus for late radiotherapy toxicity at 2q24.1. Nature Genetics. 46: 891-4. PMID 24974847 DOI: 10.1038/Ng.3020  0.413
2014 Barnett GC, Thompson D, Fachal L, Kerns S, Talbot C, Elliott RM, Dorling L, Coles CE, Dearnaley DP, Rosenstein BS, Vega A, Symonds P, Yarnold J, Baynes C, Michailidou K, et al. A genome wide association study (GWAS) providing evidence of an association between common genetic variants and late radiotherapy toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 111: 178-85. PMID 24785509 DOI: 10.1016/J.Radonc.2014.02.012  0.359
2014 Kerns SL, Ostrer H, Rosenstein BS. Radiogenomics: using genetics to identify cancer patients at risk for development of adverse effects following radiotherapy. Cancer Discovery. 4: 155-65. PMID 24441285 DOI: 10.1158/2159-8290.Cd-13-0197  0.397
2014 Andreassen C, Barnett G, Kerns S, Vega A, Talbot C, De Ruyck K, Parliament M, Koch C, Gutiérrez-Enríquez S, Alsner J. OC-0143: Analysis of 5434 patients shows a link between the ATM codon 1853 SNP and the risk of radiation-induced toxicity Radiotherapy and Oncology. 111: S55-S56. DOI: 10.1016/S0167-8140(15)30248-6  0.363
2014 Kerns S, Barnett G, Dorling L, Fachal L, Burnet N, Ostrer H, Parliament M, Rosenstein B, Vega A, West C. OC-0142: Radiogenomics consortium meta-analysis of genome wide association studies of prostate radiotherapy late toxicity Radiotherapy and Oncology. 111: S55. DOI: 10.1016/S0167-8140(15)30247-4  0.381
2014 Fachal L, Gomez-Caamaño A, Barnett G, Kerns S, Rosenstein B, West C, Dunning A, Vega A, Rapper. OC-0054: A three stage genome wide association study reveals susceptibility for late radiotherapy toxicity at the 2q24 locus Radiotherapy and Oncology. 111. DOI: 10.1016/S0167-8140(15)30159-6  0.325
2014 Andreassen C, Kerns S, Rosenstein B, Barnett G, Fachal L, Vega A, Talbot C, De Ruyck K, Parliament M, Koch A, Gutiérrez-Enríquez S, Chang-Claude J, Yarnold J, Bentzen S, Elliott R, et al. Possession of the ATM Codon 1853 SNP is Associated With an Increased Risk for Radiation-Induced Toxicity International Journal of Radiation Oncology*Biology*Physics. 90: S148-S149. DOI: 10.1016/J.Ijrobp.2014.05.622  0.357
2014 Fachal L, Gomez-Caamaño A, Barnett G, Kerns S, Rosenstein B, West C, Dunning A, Vega A. Identification of a Locus at 2q24 Associated With Susceptibility for Late Radiation Therapy Toxicity Through Performance of a 3-Stage Genome-Wide Association Study International Journal of Radiation Oncology*Biology*Physics. 90: S55-S56. DOI: 10.1016/J.Ijrobp.2014.05.196  0.356
2014 Kerns S, Barnett G, Dorling L, Faschal L, Burnet N, Dunning A, Gómez-Caamaño A, Ostrer H, Parliament M, Pharoah P, Stock R, Stone N, Vega A, West C, Rosenstein B. Identification of Single Nucleotide Polymorphisms (SNPs) Associated With Late Toxicity Following Radiation Therapy for Prostate Cancer Through a Meta-Analysis of Genome-Wide Association Studies (GWAS) International Journal of Radiation Oncology*Biology*Physics. 90: S55. DOI: 10.1016/J.Ijrobp.2014.05.195  0.332
2013 Kerns SL, Stock RG, Stone NN, Blacksburg SR, Rath L, Vega A, Fachal L, Gómez-Caamaño A, De Ruysscher D, Lammering G, Parliament M, Blackshaw M, Sia M, Cesaretti J, Terk M, et al. Genome-wide association study identifies a region on chromosome 11q14.3 associated with late rectal bleeding following radiation therapy for prostate cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 107: 372-6. PMID 23719583 DOI: 10.1016/J.Radonc.2013.05.001  0.418
2013 Kerns SL, Stone NN, Stock RG, Rath L, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of urinary symptoms after radiotherapy for prostate cancer. The Journal of Urology. 190: 102-8. PMID 23376709 DOI: 10.1016/J.Juro.2013.01.096  0.395
2013 Buckstein M, Kerns S, Forysthe K, Stone NN, Stock RG. Temporal patterns of selected late toxicities in patients treated with brachytherapy or brachytherapy plus external beam radiation for prostate adenocarcinoma. Bju International. 111: E43-7. PMID 23046084 DOI: 10.1111/J.1464-410X.2012.11436.X  0.369
2013 Kerns SL, Stock R, Stone N, Buckstein M, Shao Y, Campbell C, Rath L, De Ruysscher D, Lammering G, Hixson R, Cesaretti J, Terk M, Ostrer H, Rosenstein BS. A 2-stage genome-wide association study to identify single nucleotide polymorphisms associated with development of erectile dysfunction following radiation therapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 85: e21-8. PMID 23021708 DOI: 10.1016/J.Ijrobp.2012.08.003  0.434
2013 Blacksburg S, Kerns S, Stone N, Stock R. Predicting Long-term Disease State Outcomes in Patients With Prostate Cancer Treated With Definitive Radiation International Journal of Radiation Oncology*Biology*Physics. 87: S369-S370. DOI: 10.1016/J.Ijrobp.2013.06.970  0.353
2012 Barnett GC, Elliott RM, Alsner J, Andreassen CN, Abdelhay O, Burnet NG, Chang-Claude J, Coles CE, Gutiérrez-Enríquez S, Fuentes-Raspall MJ, Alonso-Muñoz MC, Kerns S, Raabe A, Symonds RP, Seibold P, et al. Individual patient data meta-analysis shows no association between the SNP rs1800469 in TGFB and late radiotherapy toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 105: 289-95. PMID 23199655 DOI: 10.1016/J.Radonc.2012.10.017  0.334
2012 Kerns SL, Schultz KM, Barry KA, Thorne TM, McGarry TJ. Geminin is required for zygotic gene expression at the Xenopus mid-blastula transition. Plos One. 7: e38009. PMID 22662261 DOI: 10.1371/Journal.Pone.0038009  0.617
2012 Parliament M, Broadhurst D, Ghosh S, Zhu G, Kerns S, Rosenstein B, Khitrov G, Ostrer H, Warkentin B, Murray D. Single-Nucleotide Polymorphisms (SNPs) Associated With Radiation Proctitis From Genome-wide False Discovery Rate Analysis International Journal of Radiation Oncology*Biology*Physics. 84: S712-S713. DOI: 10.1016/J.Ijrobp.2012.07.1907  0.342
2012 Kerns S, Stock R, Stone N, Rath L, Ostrer H, Rosenstein B. Genome Wide Association Study to Identify Genetic Variants Associated With Urinary Symptoms Following Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S401-S402. DOI: 10.1016/J.Ijrobp.2012.07.1060  0.414
2011 Kerns S, Stone N, Stock R, Shao Y, Ostrer H, Rosenstein B. 344 GENETIC FACTORS INFLUENCE TIME TO UNDETECTABLE PSA IN MEN WITH PROSTATE CANCER TREATED BY RADIOTHERAPY Journal of Urology. 185. DOI: 10.1016/J.Juro.2011.02.428  0.358
2010 Kerns SL, Ostrer H, Stock R, Li W, Moore J, Pearlman A, Campbell C, Shao Y, Stone N, Kusnetz L, Rosenstein BS. Genome-wide association study to identify single nucleotide polymorphisms (SNPs) associated with the development of erectile dysfunction in African-American men after radiotherapy for prostate cancer. International Journal of Radiation Oncology, Biology, Physics. 78: 1292-300. PMID 20932654 DOI: 10.1016/J.Ijrobp.2010.07.036  0.412
2007 Kerns SL, Torke SJ, Benjamin JM, McGarry TJ. Geminin prevents rereplication during xenopus development. The Journal of Biological Chemistry. 282: 5514-21. PMID 17179155 DOI: 10.1074/Jbc.M609289200  0.621
2007 Kerns SL, Torke SJ, Benjamin JM, McGarry TJ. Geminin prevents rereplication during Xenopus development Journal of Biological Chemistry. 282: 5514-5521. DOI: 10.1074/jbc.M609289200  0.604
Low-probability matches (unlikely to be authored by this person)
2021 Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, ... ... Kerns SL, et al. Publisher Correction: Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics. PMID 33473200 DOI: 10.1038/s41588-021-00786-2  0.299
2016 Frisina RD, Wheeler HE, Fossa SD, Kerns SL, Fung C, Sesso HD, Monahan PO, Feldman DR, Hamilton R, Vaughn DJ, Beard CJ, Budnick A, Johnson EM, Ardeshir-Rouhani-Fard S, Einhorn LH, et al. Comprehensive Audiometric Analysis of Hearing Impairment and Tinnitus After Cisplatin-Based Chemotherapy in Survivors of Adult-Onset Cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. PMID 27354478 DOI: 10.1200/Jco.2016.66.8822  0.298
2019 Inglis JE, Lin PJ, Kerns SL, Kleckner IR, Kleckner AS, Castillo DA, Mustian KM, Peppone LJ. Nutritional Interventions for Treating Cancer-Related Fatigue: A Qualitative Review. Nutrition and Cancer. 1-20. PMID 30688088 DOI: 10.1080/01635581.2018.1513046  0.298
2014 Kerns SL, de Ruysscher D, Andreassen CN, Azria D, Barnett GC, Chang-Claude J, Davidson S, Deasy JO, Dunning AM, Ostrer H, Rosenstein BS, West CM, Bentzen SM. STROGAR - STrengthening the Reporting Of Genetic Association studies in Radiogenomics. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 110: 182-8. PMID 23993398 DOI: 10.1016/J.Radonc.2013.07.011  0.297
2016 De Ruysscher D, Defraene G, Ramaekers BLT, Lambin P, Briers E, Stobart H, Ward T, Bentzen SM, Van Staa T, Azria D, Rosenstein B, Kerns S, West C. Optimal design and patient selection for interventional trials using radiogenomic biomarkers: A REQUITE and Radiogenomics consortium statement. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. 121: 440-446. PMID 27979370 DOI: 10.1016/J.Radonc.2016.11.003  0.297
2023 Sun Y, Tsai Y, Wood R, Shen B, Chen J, Zhou Z, Zeng G, Marples B, Kerns S, Chen Y. KDM3B SNPs impact radiation therapy toxicity through circular RNA-mediated KDM3B expression and inflammatory responses. International Journal of Radiation Oncology, Biology, Physics. PMID 38008196 DOI: 10.1016/j.ijrobp.2023.11.033  0.296
2015 Ko HC, Powers AR, Sheu RD, Kerns SL, Rosenstein BS, Krieger SC, Mourad WF, Hu KS, Gupta V, Bakst RL. Lhermitte's Sign following VMAT-Based Head and Neck Radiation-Insights into Mechanism. Plos One. 10: e0139448. PMID 26448647 DOI: 10.1371/Journal.Pone.0139448  0.296
2015 Rosenstein BS, Capala J, Efstathiou JA, Hammerbacher J, Kerns SL, Kong FS, Ostrer H, Prior FW, Vikram B, Wong J, Xiao Y. How Will Big Data Improve Clinical and Basic Research in Radiation Therapy? International Journal of Radiation Oncology, Biology, Physics. PMID 26797542 DOI: 10.1016/J.Ijrobp.2015.11.009  0.295
2022 Kerns SL, Amidon Morlang A, Lee SM, Peterson DR, Marples B, Zhang H, Bylund K, Rosenzweig D, Hall W, De Ruyck K, Rosenstein BS, Stock RG, Gómez-Caamaño A, Vega A, Sosa-Fajardo P, et al. Use of Angiotensin Converting Enzyme Inhibitors is Associated with Reduced Risk of Late Bladder Toxicity Following Radiotherapy for Prostate Cancer. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 35077710 DOI: 10.1016/j.radonc.2022.01.014  0.295
2012 Ko E, Kerns S, Stone N, Stock R, Ostrer H, Rosenstein B. Association of Genetic Factors With PSA Response in Prostate Cancer Patients Receiving Definitive Radiation Therapy International Journal of Radiation Oncology*Biology*Physics. 84: S403-S404. DOI: 10.1016/J.Ijrobp.2012.07.1066  0.295
2020 Kang J, Coates JT, Strawderman RL, Rosenstein BS, Kerns SL. Genomics models in radiotherapy: From mechanistic to machine learning. Medical Physics. 47: e203-e217. PMID 32418335 DOI: 10.1002/Mp.13751  0.294
2016 Fung C, Williams A, Sesso HD, Kerns SL, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Liu H, Fossa SD, Einhorn LH, Travis LB. Cardiovascular disease (CVD) risk factors and health behaviors following cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS). Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 34: 129. PMID 28151278 DOI: 10.1200/Jco.2016.34.3_Suppl.129  0.289
2023 Wang A, Shen J, Rodriguez AA, Saunders EJ, Chen F, Janivara R, Darst BF, Sheng X, Xu Y, Chou AJ, Benlloch S, Dadaev T, Brook MN, Plym A, Sahimi A, ... ... Kerns SL, et al. Characterizing prostate cancer risk through multi-ancestry genome-wide discovery of 187 novel risk variants. Nature Genetics. PMID 37945903 DOI: 10.1038/s41588-023-01534-4  0.288
2017 Constine LS, Termer NK, Holub D, Fung C, Adams MJ, Dhakal S, Bruckner LB, Marsh B, Kerns SL, Noyes K, Williams A, Fritsch S, Lustig C, Lynch C, Nelson S, et al. An integrative approach to personalized cancer survivorship care at an academic medical center. Journal of Clinical Oncology. 35: 37-37. DOI: 10.1200/Jco.2017.35.5_Suppl.37  0.287
2016 Zaid MIA, Fung C, Williams A, Sesso HD, Kerns SL, Ardeshir-Rouhani-Fard S, Feldman DR, Hamilton RJ, Vaughn DJ, Beard C, Monahan P, Fossa SD, Einhorn LH, Travis LB. Cardiovascular disease (CVD) risk factors and health behaviors after cisplatin-based chemotherapy (CHEM): A multi-institutional study of testicular cancer survivors (TCS) in the Platinum study. Journal of Clinical Oncology. 34: 10087-10087. DOI: 10.1200/Jco.2016.34.15_Suppl.10087  0.283
2019 Peppone LJ, Inglis JE, Mustian KM, Heckler CE, Padula GDA, Mohile SG, Kamen CS, Culakova E, Lin PJ, Kerns SL, Cole S, Janelsins MC. Multicenter Randomized Controlled Trial of Omega-3 Fatty Acids Versus Omega-6 Fatty Acids for the Control of Cancer-Related Fatigue Among Breast Cancer Survivors. Jnci Cancer Spectrum. 3: pkz005. PMID 31119206 DOI: 10.1093/Jncics/Pkz005  0.281
2018 Deasy J, Lee S, Oh J, Kerns S, Orstrer H, Rosenstein B. SP-0484: Machine Learning of radiogenomics SNP GWAS to predict complication risk and to identify key biological correlates Radiotherapy and Oncology. 127: S249. DOI: 10.1016/S0167-8140(18)30794-1  0.279
2016 Knoll MA, Salvatore M, Sheu RD, Knoll AD, Kerns SL, Lo YC, Rosenzweig KE. The use of isodose levels to interpret radiation induced lung injury: a quantitative analysis of computed tomography changes. Quantitative Imaging in Medicine and Surgery. 6: 35-41. PMID 26981453 DOI: 10.3978/J.Issn.2223-4292.2016.02.07  0.275
2017 Peppone LJ, Mustian KM, Peoples AR, Kerns SL, Reschke JE, Cole C, Janelsins MC, Asare M, Kamen CS, Culakova E, Zhang H, Fung C, Lin P, Mohile SG. A phase II RCT of high-dose vitamin D supplementation for androgen deprivation therapy (ADT)-induced bone loss among older prostate cancer (PCa) patients. Journal of Clinical Oncology. 35: 10113-10113. DOI: 10.1200/Jco.2017.35.15_Suppl.10113  0.275
2023 Naderi E, Aguado-Barrera ME, Schack LMH, Dorling L, Rattay T, Fachal L, Summersgill H, Martínez-Calvo L, Welsh C, Dudding T, Odding Y, Varela-Pazos A, Jena R, Thomson DJ, Steenbakkers RJHM, ... ... Kerns SL, et al. Large-Scale Meta-GWAS Reveals Common Genetic Factors Linked to Radiation-Induced Acute Toxicities across Cancers. Jnci Cancer Spectrum. PMID 37862240 DOI: 10.1093/jncics/pkad088  0.275
2021 Conti DV, Darst BF, Moss LC, Saunders EJ, Sheng X, Chou A, Schumacher FR, Olama AAA, Benlloch S, Dadaev T, Brook MN, Sahimi A, Hoffmann TJ, Takahashi A, Matsuda K, ... ... Kerns SL, et al. Trans-ancestry genome-wide association meta-analysis of prostate cancer identifies new susceptibility loci and informs genetic risk prediction. Nature Genetics. PMID 33398198 DOI: 10.1038/s41588-020-00748-0  0.274
2014 Rosenstein BS, West CM, Bentzen SM, Alsner J, Andreassen CN, Azria D, Barnett GC, Baumann M, Burnet N, Chang-Claude J, Chuang EY, Coles CE, Dekker A, De Ruyck K, De Ruysscher D, ... ... Kerns SL, et al. Radiogenomics: radiobiology enters the era of big data and team science. International Journal of Radiation Oncology, Biology, Physics. 89: 709-13. PMID 24969789 DOI: 10.1016/J.Ijrobp.2014.03.009  0.272
2018 Morton LM, Kerns SL, Dolan ME. Role of Germline Genetics in Identifying Survivors at Risk for Adverse Effects of Cancer Treatment. American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting. 775-786. PMID 30231410 DOI: 10.1200/EDBK_201391  0.268
2013 De Ruysscher D, Sharifi H, Defraene G, Kerns SL, Christiaens M, De Ruyck K, Peeters S, Vansteenkiste J, Jeraj R, Van Den Heuvel F, van Elmpt W. Quantification of radiation-induced lung damage with CT scans: the possible benefit for radiogenomics. Acta Oncologica (Stockholm, Sweden). 52: 1405-10. PMID 23957564 DOI: 10.3109/0284186X.2013.813074  0.264
2019 Kerns SL, Fung C, Fossa SD, Dinh PC, Monahan PO, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn DJ, Martin NE, Huddart RA, Kollmannsberger CK, Sahasrabudhe DM, Ardeshirrouhanifard S, et al. Impact of cisplatin-related adverse health outcomes (AHOs) on employment outcomes and self-reported health (SRH) among testicular cancer survivors (TCS). Journal of Clinical Oncology. 37. DOI: 10.1200/Jco.2019.37.15_Suppl.E16058  0.261
2020 Kerns SL, Fung C, Fossa SD, Dinh PC, Monahan P, Sesso HD, Frisina RD, Feldman DR, Hamilton RJ, Vaughn D, Martin N, Huddart R, Kollmannsberger C, Sahasrabudhe D, Ardeshir-Rouhani-Fard S, et al. Relationship of Cisplatin-Related Adverse Health Outcomes With Disability and Unemployment Among Testicular Cancer Survivors. Jnci Cancer Spectrum. 4: pkaa022. PMID 32704617 DOI: 10.1093/Jncics/Pkaa022  0.261
2015 Oh J, Kerns S, Ostrer H, Rosenstein B, Deasy J. OC-0082: A machine learning method demonstrates that a large number of SNPs contribute to clinical radiosensitivity Radiotherapy and Oncology. 115: S41-S42. DOI: 10.1016/S0167-8140(15)40082-9  0.258
2023 Kerns SL, Hall WA, Marples B, West CML. Normal Tissue Toxicity Prediction: Clinical Translation on the Horizon. Seminars in Radiation Oncology. 33: 307-316. PMID 37331785 DOI: 10.1016/j.semradonc.2023.03.010  0.252
2014 Kerns SL, Guevara-Aguirre J, Andrew S, Geng J, Guevara C, Guevara-Aguirre M, Guo M, Oddoux C, Shen Y, Zurita A, Rosenfeld RG, Ostrer H, Hwa V, Dauber A. A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes. The Journal of Clinical Endocrinology and Metabolism. 99: E2117-22. PMID 25057881 DOI: 10.1210/Jc.2014-1949  0.248
2021 Rares Franco N, Carlotta Massi M, Ieva F, Manzoni A, Maria Paganoni A, Zunino P, Veldeman L, Ost P, Fonteyne V, Talbot CJ, Rattay T, Webb A, Johnson K, Lambrecht M, Haustermans K, ... ... Kerns SL, et al. Development of a method for generating SNP interaction-aware polygenic risk scores for radiotherapy toxicity. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 33838170 DOI: 10.1016/j.radonc.2021.03.024  0.239
2023 Kerns SL, Williams JP, Marples B. Modeling Normal Bladder Injury After Radiation Therapy. International Journal of Radiation Biology. 1-13. PMID 36854008 DOI: 10.1080/09553002.2023.2182000  0.236
2022 Barnett GC, Kerns SL, Dorling L, Fachal L, Aguado-Barrera ME, Martínez-Calvo L, Jandu HK, Welsh C, Tyrer J, Coles CE, Haviland JS, Parker C, Gómez-Caamaño A, Calvo-Crespo P, Sosa-Fajardo P, et al. No association between polygenic risk scores for cancer and development of radiotherapy toxicity. International Journal of Radiation Oncology, Biology, Physics. PMID 35840111 DOI: 10.1016/j.ijrobp.2022.06.098  0.228
2022 Heumann P, Aguado-Barrera ME, Avuzzi B, Azria D, Briers E, Bultijnck R, Choudhury A, De Ruysscher D, Farcy-Jacquet MP, Fonteyne V, Gómez Caamaño A, Helmbold I, Johnson K, Kerns SL, Lambrecht M, et al. Comparing symptom reporting by prostate cancer patients and healthcare professionals in the international multicentre REQUITE study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 36442608 DOI: 10.1016/j.radonc.2022.11.015  0.224
2012 Liu J, Ko E, Kerns S, Stone N, Stock R. Adjusted Intermediate and High-Risk Stratification for Prostate Cancer Is More Prognostic Than Current NCCN Risk Grouping International Journal of Radiation Oncology*Biology*Physics. 84: S383. DOI: 10.1016/j.ijrobp.2012.07.1010  0.208
2013 Cespedes MS, Kerns SL, Holzman RS, McLaren PJ, Ostrer H, Aberg JA. Genetic predictors of cervical dysplasia in African American HIV-infected women: ACTG DACS 268. Hiv Clinical Trials. 14: 292-302. PMID 24334182 DOI: 10.1310/Hct1406-292  0.206
2017 De Ruysscher D, Defraene G, Ramaekers B, Lambin P, Briers E, Stobart H, Ward T, Bentzen S, Van Staa T, Kerns S, West C. EP-1419: Optimal design and patient selection for interventional trials using radiogenomic biomarkers Radiotherapy and Oncology. 123: S758-S759. DOI: 10.1016/S0167-8140(17)31854-6  0.206
2012 Guevara-Aguirre J, Guevara-Aguirre M, Hwa V, Prócel P, Saavedra J, Ostrer H, Fang P, Rosenfeld RG, Kerns S, Rosenbloom AL. Intrauterine and postnatal growth failure with normal GH/IGF1 axis and insulin-resistant diabetes in a consanguineous kinship. European Journal of Endocrinology / European Federation of Endocrine Societies. 166: 521-9. PMID 22170795 DOI: 10.1530/Eje-11-0769  0.195
2022 Groves AM, Paris N, Hernady E, Johnston CJ, Aljitawi O, Lee YF, Kerns SL, Marples B. Prevention of radiation-induced bladder injury: A murine study using captopril. International Journal of Radiation Oncology, Biology, Physics. PMID 36400304 DOI: 10.1016/j.ijrobp.2022.10.033  0.194
2022 Van der Weijst L, Aguado-Barrera ME, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Calvo-Crespo P, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Dunning AM, Elliott RM, Ennis D, ... ... Kerns SL, et al. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study). Lung Cancer (Amsterdam, Netherlands). 166: 228-241. PMID 35334417 DOI: 10.1016/j.lungcan.2022.03.010  0.181
2014 West C, Rosenstein B, Bentzen S, Barnett G, Dunning A, Kerns S, Chang-Claude J, Deasy J, Andreassen C. EP-1822: The Radiogenomics Consortium (RGC) Radiotherapy and Oncology. 111: S297. DOI: 10.1016/S0167-8140(15)31940-X  0.178
2022 Webb AJ, Harper E, Rattay T, Aguado-Barrera ME, Azria D, Bourgier C, Brengues M, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Cicchetti A, De Ruysscher D, De Santis MC, Dunning AM, ... ... Kerns SL, et al. Treatment time and circadian genotype interact to influence radiotherapy side-effects. A prospective European validation study using the REQUITE cohort. Ebiomedicine. 84: 104269. PMID 36130474 DOI: 10.1016/j.ebiom.2022.104269  0.175
2022 van der Weijst L, Azria D, Berkovic P, Boisselier P, Briers E, Bultijnck R, Chang-Claude J, Choudhury A, Defraene G, Demontois S, Elliott RM, Ennis D, Faivre-Finn C, Franceschini M, Giandini T, ... ... Kerns SL, et al. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study. Radiotherapy and Oncology : Journal of the European Society For Therapeutic Radiology and Oncology. PMID 36195214 DOI: 10.1016/j.radonc.2022.09.020  0.174
2022 Kleckner AS, Kleckner IR, Culakova E, Wojtovich AP, Klinedinst NJ, Kerns SL, Hardy SJ, Inglis JE, Padula GDA, Mustian KM, Janelsins MC, Dorsey SG, Saligan LN, Peppone LJ. Exploratory Analysis of Associations Between Whole Blood Mitochondrial Gene Expression and Cancer-Related Fatigue Among Breast Cancer Survivors. Nursing Research. PMID 35416182 DOI: 10.1097/NNR.0000000000000598  0.167
2012 Buckstein M, Kerns S, Stock R, Stone N, Rath L, Ostrer H, Rosenstein B. Genome-wide Association Study to Identify Genetic Variants Associated With the Development of Erectile Dysfunction Following Radiation Therapy for Prostate Cancer International Journal of Radiation Oncology*Biology*Physics. 84: S50. DOI: 10.1016/J.Ijrobp.2012.07.339  0.157
2021 Janelsins MC, Lei L, Netherby-Winslow C, Kleckner AS, Kerns S, Gilmore N, Belcher E, Thompson BD, Werner ZA, Hopkins JO, Long J, Cole S, Culakova E. Relationships between cytokines and cognitive function from pre- to post-chemotherapy in patients with breast cancer. Journal of Neuroimmunology. 362: 577769. PMID 34871864 DOI: 10.1016/j.jneuroim.2021.577769  0.12
2015 Barnett GC, Kerns SL, Noble DJ, Dunning AM, West CML, Burnet NG. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity Clinical Oncology. DOI: 10.1016/j.clon.2015.06.013  0.116
Hide low-probability matches.